The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.

Inventor: Colin Parrish

Canigen CPV2b

Canigen CPV2b is a vaccine comprised of live attenuated canine parvovirus 2b Strain CPV39 and is approved for use in puppies from the age of five weeks to induce protection against CPV serotypes 2b, 2a and 2.